The relationship between postoperative decline of serum CA 125 levels and size of residual disease after initial surgery in patients with advanced ovarian cancer: A CTF study

被引:14
|
作者
Gadducci, A
Landoni, F
Maggino, T
Sartori, E
Zola, P
Fanucchi, A
机构
[1] UNIV MILAN,BRANCH 3,DEPT OBSTET & GYNECOL,MONZA,MILANO,ITALY
[2] UNIV PADUA,DEPT OBSTET & GYNECOL,PADUA,ITALY
[3] UNIV BRESCIA,DEPT OBSTET & GYNECOL,BRESCIA,ITALY
[4] UNIV TURIN,DEPT OBSTET & GYNECOL,TURIN,ITALY
关键词
D O I
10.1006/gyno.1996.0312
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
This retrospective study assessed 46 patients with advanced ovarian cancer who had elevated preoperative serum CA 125 (>35 U/ml) and who had another serum CA 125 assay 6-9 days after surgery, Preoperative CA 125 levels were similar in patients with residual disease below 20 mm and in those with larger residuum, The postoperative decline of serum CA 125 was significantly higher in patients with small residual disease at any preoperative serum CA 125 value, By taking 60% as the cutoff of CA 125 decline, the diagnostic accuracy of this parameter in discriminating between patients with residual disease below or above 20 mm improved progressively when we considered patients with increasing preoperative antigen values, However, even in the subset of patients with preoperative serum CA 125 above 400 U/ml, 2 of the 20 patients with less than 20 mm residual disease had a percentage reduction of antigen levels lower than 60%, whereas 5 of the 10 patients with larger than 20 mm residuum had a CA 125 decline higher than 60%. Therefore, we believe that the perioperative changes of CA 125 levels have a limited clinical relevance in the mangagement of patients with ovarian cancer. (C) 1996 Academic Press, Inc.
引用
收藏
页码:234 / 237
页数:4
相关论文
共 50 条
  • [41] DEVELOPMENT AND EXTERNAL VALIDATION OF A MODEL TO PREDICT RESIDUAL DISEASE AFTER DEBULKING SURGERY IN ADVANCED OVARIAN CANCER PATIENTS USING COMPUTED TOMOGRAPHY FINDINGS
    Rutten, M. J.
    Van de Vrie, R.
    Schuit, E.
    Bruining, A.
    Spijkerboer, A.
    Van Waesberghe, J. H. T. M.
    Mol, B. W. J.
    Kenter, G. G.
    Buist, M. R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2015, 25 (09) : 540 - 541
  • [42] Impact of no residual disease on postoperative computed tomography on survival in patients with optimally debulked advanced high-grade serous ovarian cancer during upfront surgery
    Lim, Hyunji
    Shim, Jung In
    Park, Soo Jin
    Noh, Joseph
    Kim, Taek Min
    Lee, Maria
    Choi, Chel Hun
    Chung, Hyun Hoon
    Kim, Tae-Joong
    Lee, Jeong-Won
    Kim, Jae-Weon
    Kim, Byoung-Gie
    Park, Noh Hyun
    Song, Yong Sang
    Kim, Sang Youn
    Park, Sung Yoon
    Kim, Hee Seung
    Lee, Yoo-Young
    GYNECOLOGIC ONCOLOGY, 2022, 165 (03) : 493 - 499
  • [43] ASO Visual Abstract: Visual Peritoneal Evaluation of Residual Disease After Neoadjuvant Chemotherapy in Advanced Ovarian Cancer Patients—The VIPER Study
    Barbara Costantini
    Andrea Rosati
    Virginia Vargiu
    Vitalba Gallitelli
    Chiara Di Ilio
    Rossana Moroni
    Giovanni Scambia
    Anna Fagotti
    Annals of Surgical Oncology, 2023, 30 : 2329 - 2330
  • [44] Prognostic significance of CA-125 re-elevation after interval debulking surgery in patients with advanced-stage ovarian cancer undergoing neoadjuvant chemotherapy
    Lee, Yong Jae
    Chung, Young Shin
    Lee, Jung-Yun
    Nam, Eun Ji
    Kim, Sang Wun
    Kim, Sunghoon
    Kim, Young Tae
    EJSO, 2019, 45 (04): : 644 - 649
  • [45] CORRELATION OF CEA AND CA-125 SERUM LEVELS WITH THE PRESENCE OR ABSENCE OF DISEASE, RESPONSE TO CHEMOTHERAPY AND THE 2ND LOOK FINDINGS IN OVARIAN-CANCER PATIENTS
    BAFALOUKOS, D
    SIDIS, DP
    DIMITRIADIS, M
    TRAPALI, X
    LAFI, A
    KOUTSIOUBA, P
    ATHANASIOU, A
    EUROPEAN JOURNAL OF NUCLEAR MEDICINE, 1988, 14 (5-6): : 323 - 323
  • [46] Plasma tumor-derived small extracellular vesicles microRNAs plus CA-125 objectively detect residual disease risk after surgical debulking in advanced ovarian cancer
    Tang, J.
    ANNALS OF ONCOLOGY, 2022, 33 : S395 - S396
  • [47] Correlation of Preoperative Serum and Intraoperative Peritoneal Lavage Fluid Ca-125 Levels with Postoperative Tumor Histology in Patients with Endometrial Cancer: A Prospective-Controlled Study
    Doluoglu, Suleyman Gunhan
    Karaca, Mehmet
    Erol, Onur
    JOURNAL OF INVESTIGATIVE SURGERY, 2022, 35 (06) : 1248 - 1252
  • [48] Serum CA-125 level after 6 cycles of primary adjuvant chemotherapy is a useful prognostic factor for complete responders' survival in patients with advanced epithelial ovarian cancer
    Kim, Hee Seung
    Park, Noh-Hyun
    Chung, Hyun Hoon
    Kim, Jae Weon
    Song, Yong-Sang
    Kang, Soon-Beom
    ONKOLOGIE, 2008, 31 (06): : 315 - 320
  • [49] Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study
    Na Guo
    Zhilan Peng
    Journal of Ovarian Research, 10
  • [50] Does serum CA125 have clinical value for follow-up monitoring of postoperative patients with epithelial ovarian cancer? Results of a 12-year study
    Guo, Na
    Peng, Zhilan
    JOURNAL OF OVARIAN RESEARCH, 2017, 10